Efavirenz 69097-0301-02
- Manufacturer
- Cipla Usa Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 18, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA204766
Need to source Efavirenz? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Efavirenz | 600 mg/1 |
Drug Class
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Cytochrome P450 2B6 Inducers [MoA]Cytochrome P450 2C19 Inhibitors [MoA]
Selected Package
69097-0301-02Selected30 TABLET, FILM COATED in 1 BOTTLE (69097-301-02)